The cyclooxygenase-2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II-III A phase II trial.

Source:http://linkedlifedata.com/resource/pubmed/id/16188370

Eur. J. Obstet. Gynecol. Reprod. Biol. 2006 Apr 1 125 2 251-4

Download in:

View as

General Info

PMID
16188370